methamphetamine has been researched along with 3-o-methyl-alpha-methyldopamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chei, DM; Foltz, RL; Lim, HK; Zeng, S | 1 |
| Brenneisen, R; Lanz, M; Thormann, W | 1 |
| Abraham, TT; Huestis, MA; Pirnay, SO | 1 |
| Abraham, TT; Huestis, MA; Lowe, RH; Pirnay, SO | 1 |
| Cody, JT; Phelix, CF; Valtier, S | 1 |
| Huestis, MA; Kolbrich, EA; Lowe, RH | 1 |
| Bastos, ML; Branco, P; Carmo, H; Carvalho, F; da Silva, DG; de Pinho, PG; Ferreira, L; Pontes, H; Remião, F | 1 |
| Baumann, MH; Blough, BE; Goldberg, SR; Schindler, CW; Tella, SR; Thorndike, EB | 1 |
8 other study(ies) available for methamphetamine and 3-o-methyl-alpha-methyldopamine
| Article | Year |
|---|---|
Comparative investigation of disposition of 3,4-(methylenedioxy)methamphetamine (MDMA) in the rat and the mouse by a capillary gas chromatography-mass spectrometry assay based on perfluorotributylamine-enhanced ammonia positive ion chemical ionization.
Topics: 3,4-Methylenedioxyamphetamine; Ammonia; Animals; Dopamine; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Male; Methamphetamine; Mice; Mice, Inbred Strains; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Species Specificity | 1992 |
Enantioselective determination of 3,4-methylene-dioxymethamphetamine and two of its metabolites in human urine by cyclodextrin-modified capillary zone electrophoresis.
Topics: 3,4-Methylenedioxyamphetamine; Cyclodextrins; Dopamine; Electrophoresis, Capillary; Humans; Methamphetamine; Molecular Conformation; N-Methyl-3,4-methylenedioxyamphetamine | 1997 |
Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Calibration; Central Nervous System Stimulants; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Substance Abuse Detection | 2006 |
Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Dopamine; Forensic Toxicology; Glucuronidase; Hallucinogens; Humans; Hydrochloric Acid; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2006 |
Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biotransformation; Calibration; Dopamine; Gas Chromatography-Mass Spectrometry; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Rats; Reproducibility of Results; Toxicology | 2007 |
Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.
Topics: 3,4-Methylenedioxyamphetamine; Calibration; Central Nervous System Stimulants; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection | 2008 |
Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Dopamine; Gas Chromatography-Mass Spectrometry; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Sensitivity and Specificity | 2010 |
Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiovascular System; Consciousness; Deoxyepinephrine; Dopamine; Dose-Response Relationship, Drug; Hallucinogens; Heart Rate; Male; Metabolic Detoxication, Phase I; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Telemetry; Time Factors | 2014 |